10/3/25 17:13 | 10/1/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schultes Birgit C | MA | O | EVP,Chie | 1 | S | -1 | 17.39 | 0 | 0 | 0 | 105 | D | | | | | | | | | | | | | | |
10/3/25 17:13 | 10/1/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dube Michael P | MA | O | VP,Chief | 1 | S | -33 | 17.38 | 0 | -2 | | 55 | D | | | | | | | | | | | | | | |
10/1/25 16:55 | 9/30/25 | IONS | Ionis Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hougen Elizabeth L | CA | O | EVP,Fina | 1 | S.d | -3,250 | 65.26 | 0 | -50 | | 111 | D | | | | | | | | | | | | | | |
9/22/25 16:31 | 9/18/25 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Oki Mark K | WA | O | CFO | 1 | S.d | -146 | 2.92 | 0 | -50 | | 128 | D | | | | | | | | | | | | | | |
9/22/25 16:29 | 9/18/25 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | CEO | 1 | S.d | -378 | 2.92 | 0 | -130 | | 230 | D | | | | | | | | | | | | | | |
9/8/25 16:59 | 9/4/25 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wan Jerry | A1 | O | Principa | 1 | S.d | -39 | 2.77 | 0 | -14 | | 33 | D | | | | | | | | | | | | | | |
9/8/25 16:54 | 9/4/25 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Thomas Braxton | WA | D | | 1 | S.d | -387 | 2.77 | 0 | -140 | | 315 | D | | | | | | | | | | | | | | |
9/8/25 16:51 | 9/4/25 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | P,CMO | 1 | S.d | -77 | 2.77 | 0 | -28 | | 116 | D | | | | | | | | | | | | | | |
9/8/25 16:39 | 9/4/25 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Xinos Jaime | WA | O | Chief Co | 1 | S.d | -58 | 2.77 | 0 | -21 | | 74 | D | | | | | | | | | | | | | | |
8/21/25 17:27 | 8/19/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Patel Rajiv A | CA | H | Member o | 1 | S.m | -191,214 | 56.14 | 0 | -3,406 | | 3,477 | I | | | | | | | | | | | | | | |
8/21/25 17:27 | 8/19/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Farallon Partners L L C/Ca | CA | TH | Member o | 1 | S.m | -191,214 | 56.14 | 0 | -3,406 | | 3,477 | I | | | | | | | | | | | | | | |
8/15/25 16:33 | 8/13/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | P | 1 | S | -164 | 53.57 | 0 | -3 | | 108 | D | | | | | | | | | | | | | | |
8/15/25 16:07 | 8/13/25 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jimenez Freddy A. | NJ | O | SVP,GC | 1 | S | -19 | 24.77 | 0 | -1 | | 35 | D | | | | | | | | | | | | | | |